Skip to main content

Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.

Publication ,  Journal Article
Califf, RM; Pieper, KS; Lee, KL; Van De Werf, F; Simes, RJ; Armstrong, PW; Topol, EJ
Published in: Circulation
May 16, 2000

BACKGROUND: When a patient survives thrombolysis for acute myocardial infarction, little information from large studies exists from which to estimate prognosis during follow-up visits. METHODS AND RESULTS: Baseline, in-hospital, and later survival data were collected from 41 021 patients enrolled in Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries, a randomized trial of 4 thrombolytic-heparin regimens with standard aspirin and beta-blockade. Cox proportional hazards models were developed to predict 1-year survival in 30-day survivors (n=37 869) from baseline clinical and ECG factors and in-hospital factors; a combined model then was developed (C-index 0.800). The model was simplified into a nomogram to predict individual outcomes (C-index 0.754). Factors reflecting demographics (advanced age, lighter weight), larger infarctions (higher Killip class, lower blood pressure, faster heart rate, longer QRS duration), cardiac risk (smoking, hypertension, prior cerebrovascular disease), and arrhythmia were important predictors of death between 30 days and 1 year. Black race was associated with a substantial increase in risk after considering other factors. Revascularization was associated with reduced risk between 30 days and 1 year. CONCLUSIONS: When evaluating a patient who has survived acute infarction treated with thrombolysis, clinicians can estimate the likelihood of survival from factors easily measured during admission. Although many risk factors clearly relate to age, left ventricular dysfunction, or clinical instability, black race is an unexplained risk factor requiring further examination.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 16, 2000

Volume

101

Issue

19

Start / End Page

2231 / 2238

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Survival Analysis
  • Streptokinase
  • Proportional Hazards Models
  • Prognosis
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Califf, R. M., Pieper, K. S., Lee, K. L., Van De Werf, F., Simes, R. J., Armstrong, P. W., & Topol, E. J. (2000). Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation, 101(19), 2231–2238. https://doi.org/10.1161/01.cir.101.19.2231
Califf, R. M., K. S. Pieper, K. L. Lee, F. Van De Werf, R. J. Simes, P. W. Armstrong, and E. J. Topol. “Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.Circulation 101, no. 19 (May 16, 2000): 2231–38. https://doi.org/10.1161/01.cir.101.19.2231.
Califf RM, Pieper KS, Lee KL, Van De Werf F, Simes RJ, Armstrong PW, et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation. 2000 May 16;101(19):2231–8.
Califf, R. M., et al. “Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.Circulation, vol. 101, no. 19, May 2000, pp. 2231–38. Pubmed, doi:10.1161/01.cir.101.19.2231.
Califf RM, Pieper KS, Lee KL, Van De Werf F, Simes RJ, Armstrong PW, Topol EJ. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation. 2000 May 16;101(19):2231–2238.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 16, 2000

Volume

101

Issue

19

Start / End Page

2231 / 2238

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Survival Analysis
  • Streptokinase
  • Proportional Hazards Models
  • Prognosis
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans